Clinical Trial Update: Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 feasibility study evaluating interleukin-1 alpha in combination with Ifosfamide, Carboplatin, and Etoposide with autologous bone marrow transplant in me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphoma
• Testicular Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Interleukin-1 alpha (Interleukin-1 alpha)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Neoplasms, Lymphoma | Phase 1 | Status: COMPLETED